Beneficial effects of minocycline on the ovary of polycystic ovary syndrome mouse model: Molecular docking analysis and evaluation of TNF-α, TNFR2, TLR-4 gene expression-Reference-Cited by-同舟云学术

Beneficial effects of minocycline on the ovary of polycystic ovary syndrome mouse model: Molecular docking analysis and evaluation of TNF-α, TNFR2, TLR-4 gene expression

Published:2021-04 Issue: Volume:144 Page:103289
ISSN:0165-0378
Container-title:Journal of Reproductive Immunology
language:en
Short-container-title:Journal of Reproductive Immunology

Author:

Khajouei Azadeh^ORCID,Hosseini Elham^ORCID,Abdizadeh Tooba^ORCID,Kian Mahdie^ORCID,Ghasemi Sorayya^ORCID

Funder

Shahrekord University of Medical Sciences

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine,Immunology,Immunology and Allergy

Reference69 articles.

1. Evaluation of tumor necrosis factor alpha production in ex vivo short term culture whole blood from women with polycystic ovary syndrome;Araya;Eur. Cytokine Netw.,2003

2. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome;Arroyo;PLoS One,2019

3. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report;Azziz;Fertil. Steril.,2009

4. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat;Baravalle;Arch. Med. Res.,2006

5. Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models;Bastos;Eur. J. Pharmacol.,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Association of Biochemical Characterization and Genetic Determinants of TNF-α, CXCR2, and CCR5 Delta 32 Mutation with Predisposition to Polycystic Ovary Syndrome;Life;2024-07-28

2. Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats;The Journal of Physiology;2024-07-09

3. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models;Biomedicine & Pharmacotherapy;2024-05

4. Building Personalized Risk Prediction Models for Polycystic Ovary Syndrome Using Machine Learning Techniques: A Retrospective Study;2024

5. Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22